Zusammenfassung
Sechs Jahre nach Veröffentlichung soll der Nutzen der ILAE-Konsensus-Klassifikation Fokaler Kortikaler Dysplasien (FCD) bewertet werden. FCDs sind häufige Ursachen frühkindlicher und medikamentös schwierig zu behandelnder fokaler Epilepsien. Die neurochirurgische Therapie bietet oftmals eine große Chance auf dauerhafte Heilung. Dies ist aber wesentlich vom histopathologischen Subtyp abhängig, und das Resektionsfeld muss durch umfassende prächirurgische Diagnostik definiert werden, z. B. durch die vorläufige Abschätzung der Art der FCD anhand des MRT und ihre Nachbarschaftsbeziehung zu eloquenten Arealen, sowie durch iktale und interiktale EEG-Befunde. Die ILAE-Klassifikation grenzt 3 histomorphologisch unterschiedliche FCD-Subtypen ab, welche nach aktuellem Kenntnisstand auch unterschiedlichen Pathomechanismen zugrunde liegen. FCD Typ 1 sind seltene Erkrankungen bei weit überwiegend jungen Kindern mit radiologisch, elektro-klinisch als auch pathologisch schwierig zu diagnostizierenden Epilepsien – mit deutlich geringeren Chancen auf eine postoperative Anfallsfreiheit als dies bei einer FCD Typ 2 der Fall ist. Die FCD Typ 2 stellt eine klinisch-pathologisch gut charakterisierte und chirurgisch oftmals gut behandelbare Gruppe dar. Molekulargenetisch finden sich Mutationen im mTOR-Signalweg, was daran denken lässt, dass zukünftig evtl. eine zielgerichtete medikamentöse Therapie möglich wird. Währenddessen sind assoziierte FCD Typ 3 in der wissenschaftlichen Literatur zwar häufig beschrieben, ihre Entstehung und Eigenständigkeit jedoch umstritten. Klinischer Verlauf und neurochirurgischer Therapieerfolg sind meist von der Hauptläsion abhängig, welche mit Hippocampussklerosen (HS), epilepsieassoziierten Tumoren (LEAT), vaskulären Fehlbildungen, Enzephalitiden und anderen frühkindlichen erworbenen Läsionen ein breites Spektrum abdecken. Eine Revision der bestehenden ILAE-Klassifikation wird bereits diskutiert, v. a. um dem Einzug molekulardiagnostischer Methoden wie in vielen anderen Bereichen der Medizin gerecht zu werden. Wesentliche Änderungen im bestehenden Prinzip in der Einteilung der drei FCD-Typen sind allerding nicht zu erwarten.
Abstract
We would like to discuss the benefits as well as ongoing challenges of the International League Against Epilepsy (ILAE) first consensus classification of focal cortical dysplasia (FCD) published in 2011. FCD is a frequent cause of early onset and drug-resistant focal epilepsy. Success of neurosurgical therapy, however, largely depends on the clinico-pathological subtype, which has been classified into three major subtypes: FCD type 1 is a rare disease frequently observed in young children and is a radiologically, electroclinically and histopathologically difficult to diagnose epilepsy. Post-surgical seizure control is less successful compared to FCD type 2A or FCD type 2B. These FCD type 2 variants are radiologically, electroclinically and histopathologically well described and probably share molecular mutations with other mTORopathies, such as hemimegalencephaly and tuberous sclerosis complex. FCD type 3 is associated with other principal lesions, such as hippocampal sclerosis (FCD 3A), epilepsy-associated tumors (FCD 3B), vascular malformations (FCD 3C) and other lesions acquired during early life (FCD 3D). The pathomechanism remains to be elucidated and success of surgical therapy is often similar to that of the principal lesions rather than being a distinct feature. An up-coming revision of the ILAE classification is currently under discussion to cover progress in molecular diagnostics (as shown in other medical disciplines, please refer to the tumor chapter of this issue); however, major changes in the three-tiered classification scheme are not expected.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10309-017-0119-0/MediaObjects/10309_2017_119_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10309-017-0119-0/MediaObjects/10309_2017_119_Fig2_HTML.gif)
Literatur
Barkovich AJ, Kuzniecky RI, Bollen AW et al (1997) Focal transmantle dysplasia: a specific malformation of cortical development. Neurology 49:1148–1152
Baulac S, Ishida S, Marsan E et al (2015) Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations. Ann Neurol 77:675–683
Becker AJ, Urbach H, Scheffler B et al (2002) Focal cortical dysplasia of Taylor’s balloon cell type: mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis. Ann Neurol 52:29–37
Blumcke I, Pieper T, Pauli E et al (2010) A distinct variant of focal cortical dysplasia type I characterised by magnetic resonance imaging and neuropathological examination in children with severe epilepsies. Epileptic Disord 12:172–180
Blumcke I, Sarnat HB (2016) Somatic mutations rather than viral infection classify focal cortical dysplasia type II as mTORopathy. Curr Opin Neurol 29(3):388–395. doi:10.1097/wco.0000000000000303
Blumcke I, Thom M, Aronica E et al (2011) The clinico-pathological spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc task force of the ILAE Diagnostic Methods Commission. Epilepsia 52:158–174
Cendes F, Cook MJ, Watson C et al (1995) Frequency and characteristics of dual pathology in patients with lesional epilepsy. Neurology 45:2058–2064
Chamberlain WA, Cohen ML, Gyure KA et al (2009) Interobserver and intraobserver reproducibility in focal cortical dysplasia (malformations of cortical development). Epilepsia 50:2593–2598
Comi AM (2003) Pathophysiology of Sturge-Weber syndrome. J Child Neurol 18:509–516
Coras R, De Boer OJ, Armstrong D et al (2012) Good interobserver and intraobserver agreement in the evaluation of the new ILAE classification of focal cortical dysplasias. Epilepsia 53:1341–1348
D’gama AM, Geng Y, Couto JA et al (2015) Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia. Ann Neurol 77:720–725
Daumas-Duport C, Scheithauer BW, Chodkiewicz JP et al (1988) Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery 23:545–556
Di Gennaro G, D’aniello A, De Risi M et al (2015) Temporal pole abnormalities in temporal lobe epilepsy with hippocampal sclerosis: clinical significance and seizure outcome after surgery. Seizure 32:84–91
Dupont E, Hanganu IL, Kilb W et al (2006) Rapid developmental switch in the mechanisms driving early cortical columnar networks. Nature 439:79–83
Fauser S, Schulze-Bonhage A (2006) Epileptogenicity of cortical dysplasia in temporal lobe dual pathology: an electrophysiological study with invasive recordings. Brain 129:82–95
Gambardella A, Palmini A, Andermann F et al (1996) Usefulness of focal rhythmic discharges on scalp EEG of patients with focal cortical dysplasia and intractable epilepsy. Electroencephalogr Clin Neurophysiol 98:243–249
Garbelli R, Milesi G, Medici V et al (2012) Blurring in patients with temporal lobe epilepsy: clinical, high-field imaging and ultrastructural study. Brain 135:2337–2349
Harvey AS, Cross JH, Shinnar S et al (2008) Defining the spectrum of international practice in pediatric epilepsy surgery patients. Epilepsia 49:146–155
Harvey AS, Mandelstam SA, Maixner WJ et al (2015) The surgically remediable syndrome of epilepsy associated with bottom-of-sulcus dysplasia. Neurology 84:2021–2028
Hildebrandt M, Pieper T, Winkler P et al (2005) Neuropathological spectrum of cortical dysplasia in children with severe focal epilepsies. Acta Neuropathol 110:1–11
Holthausen H, Blumcke I (2016) Epilepsy-associated tumours: what epileptologists should know about neuropathology, terminology, and classification systems. Epileptic Disord 18:240–251
Holthausen H, Krsek P, Blumcke I (2016) Focal (isolated) cortical dysplasia Type I. In: Arzimanoglou A, Cross JH, Gaillard WD, Holthausen H, Jayakar P, Kahane P, Mathern GW (Hrsg) Pediatric epilepsy surgery. John Libbey Eurotext, Montrouge, S 133–144
Holthausen H, Pieper T, Winkler P et al (2014) Electro-clinical-pathological correlations in focal cortical dysplasia (FCD) at young ages. Childs Nerv Syst 30:2015–2026
Holthausen H, Rydenhag B, Yardi N et al (2016) Benign tumors (WHO grades I and II). In: Arzimanoglou A, Cross JH, Gaillard WD, Holthausen H, Jayakar P, Kahane P, Mathern GW (Hrsg) Pediatric epilepsy surgery. John Libbey Eurotext, Mountrouge, S 185–206
Hubel DH, Wiesel TN (1969) Anatomical demonstration of columns in the monkey striate cortex. Nature 221:747–750
Khazipov R, Luhmann HJ (2006) Early patterns of electrical activity in the develo** cerebral cortex of humans and rodents. Trends Neurosci 29:414–418
Krsek P, Pieper T, Karlmeier A et al (2009) Different presurgical characteristics and seizure outcomes in children with focal cortical dysplasia type I or II. Epilepsia 50:125–137
Krueger DA, Wilfong AA, Holland-Bouley K et al (2013) Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Ann Neurol 74:679–687
Marin-Padilla M, Parisi JE, Armstrong DL et al (2002) Shaken infant syndrome: developmental neuropathology, progressive cortical dysplasia, and epilepsy. Acta Neuropathol 103:321–332
Mountcastle VB (1997) The columnar organization of the neocortex. Brain 120(Pt 4):701–722
Muhlebner A, Coras R, Kobow K et al (2012) Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRI. Acta Neuropathol 123:259–272
Palmini A, Gambardella A, Andermann F et al (1994) Operative strategies for patients with cortical dysplastic lesions and intractable epilepsy. Epilepsia 35(Suppl 6):S57–S71
Palmini A, Najm I, Avanzini G et al (2004) Terminology and classification of the cortical dysplasias. Neurology 62:S2–S8
Palmini A, Paglioli E, Silva VD (2013) Developmental tumors and adjacent cortical dysplasia: single or dual pathology? Epilepsia 54(Suppl 9):18–24
Rojiani AM, Emery JA, Anderson KJ et al (1996) Distribution of heterotopic neurons in normal hemispheric white matter: a morphometric analysis. J Neuropathol Exp Neurol 55:178–183
Rosenow F, Alonso-Vanegas MA, Baumgartner C et al (2013) Cavernoma-related epilepsy: review and recommendations for management – report of the Surgical Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 54:2025–2035
Rowland NC, Englot DJ, Cage TA et al (2012) A meta-analysis of predictors of seizure freedom in the surgical management of focal cortical dysplasia. J Neurosurg 116:1035–1041
Scheffer IE, Heron SE, Regan BM et al (2014) Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations. Ann Neurol 75:782–787
Simpson SL, Prayson RA (2014) Post-surgical outcome for epilepsy associated with type I focal cortical dysplasia subtypes. Mod Pathol 27:1455–1460
Spreafico R (2010) Are some focal cortical dysplasias post-migratory cortical malformaitons? Epileptic Disord 12:169–171
Tassi L, Colombo N, Garbelli R et al (2002) Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain 125:1719–1732
Tassi L, Garbelli R, Colombo N et al (2012) Electroclinical, MRI and surgical outcomes in 100 epileptic patients with type II FCD. Epileptic Disord 14:257–266
Taylor DC, Falconer MA, Bruton CJ et al (1971) Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatr 34:369–387
Thom M, Eriksson S, Martinian L et al (2009) Temporal lobe sclerosis associated with hippocampal sclerosis in temporal lobe epilepsy: neuropathological features. J Neuropathol Exp Neurol 68:928–938
Urbach H, Scheffler B, Heinrichsmeier T et al (2002) Focal cortical dysplasia of Taylor’s balloon cell type: a clinicopathological entity with characteristic neuroimaging and histopathological features, and favorable postsurgical outcome. Epilepsia 43:33–40
Wagner J, Urbach H, Niehusmann P et al (2011) Focal cortical dysplasia type IIb: completeness of cortical, not subcortical, resection is necessary for seizure freedom. Epilepsia 52:1418–1424
Wolf HK, Roos D, Blumcke I et al (1996) Perilesional neurochemical changes in focal epilepsies. Acta Neuropathol 91:376–384
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
I. Blümcke, K. Kobow und H. Holthausen geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Blümcke, I., Kobow, K. & Holthausen, H. Die ILAE-Klassifikation fokaler kortikaler Dysplasien im klinischen Gebrauch. Z. Epileptol. 30, 200–207 (2017). https://doi.org/10.1007/s10309-017-0119-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10309-017-0119-0